Alteration of dopamine receptors subtypes in the brain of opioid abusers: A postmortem study in Iran

2018 ◽  
Vol 687 ◽  
pp. 169-176 ◽  
Author(s):  
Mitra-Sadat Sadat-Shirazi ◽  
Mohammad-Reza Zarrindast ◽  
Hamidreza Daneshparvar ◽  
Ali Ziaie ◽  
Monir Fekri ◽  
...  
2018 ◽  
Vol 69 (1) ◽  
pp. 49-59 ◽  
Author(s):  
Nasim Vousooghi ◽  
Mitra‐Sadat Sadat‐Shirazi ◽  
Payam Safavi ◽  
Ramin Zeraati ◽  
Ardeshir Akbarabadi ◽  
...  

Neurology ◽  
1972 ◽  
Vol 22 (9) ◽  
pp. 941-941 ◽  
Author(s):  
B. Messert ◽  
B. B. Wannamaker ◽  
A. W. Dudley

NeuroImage ◽  
2003 ◽  
Vol 19 (1) ◽  
pp. 145-155 ◽  
Author(s):  
Erkki Tupala ◽  
Håkan Hall ◽  
Tuija Mantere ◽  
Pirkko Räsänen ◽  
Terttu Särkioja ◽  
...  

2017 ◽  
Vol 63 (1) ◽  
pp. 5-12 ◽  
Author(s):  
N.L. Vekshina ◽  
P.K. Anokhin ◽  
A.G. Veretinskaya ◽  
I.Yu. Shamakina

This review summarizes modern data on the structure and functions ofheteromersformed by D1 and D2 dopamine receptors focusing on their role in the mechanisms of drug dependence. This article discusses potential functional significance of heterodimeric D1-D2 dopamine receptorsdue to their localization in the brain as well as unique pharmacological propertiesversus constituent monomers. It is shown that heteromerization results in dramatic changes in activated signaling pathways compare to the corresponding monomers. These studies update our current knowledge of ligand-receptor interactions and provide better understanding of dopamine receptors pharmacology. Furthermore elucidation of significance of heterodimeric D1-D2 dopamine receptors as drug targets is important for the development of new effective drug addiction treatment.


1992 ◽  
Vol 20 ◽  
pp. 171-173 ◽  
Author(s):  
O. Giorgi ◽  
M.G. Pibiri ◽  
R. Dal Toso ◽  
G. Toffano ◽  
G. Biggio

1984 ◽  
Vol 23 (2) ◽  
pp. 243-246 ◽  
Author(s):  
G WOODRUFF ◽  
L HOLDENDYE ◽  
K SENIOR ◽  
J POAT
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document